Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes

Internal and Emergency Medicine

Volumn 7, Issue 6, 2012, Pages 497-503

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Attanà, Paola ^a   Chiostri, Marco ^a   Picariello, Claudio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute glucose dysmetabolims; Acute heart failure; Hyperglycemia; Insulin resistance; Prognosis

Indexed keywords

EID: 84869190070     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0597-4     Document Type: Article

References (38)

1. Loomba RS, Arora R (2010) Hyperglycemia and acute coronary syndrome: a systematic review of hyperglycemia's impact on ACS. Am J Ther 17(2): e48-e51.
2. Deedwania P, Kosiborod M, Barrett E, et al., American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117(12): 1610-1619.
3. Kosiborod M, Rathore SS, Inzucchi SE (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111(23): 3078-3086.
4. Kosiborod M, Inzucchi SE, Krumholz HM et al (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117(8): 1018-1027.
5. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF (2010) Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown) 11(1): 7-13.
6. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M (2005) Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26(13): 1255-1261.
7. Goyal A, Mahaffey KW, Garg J et al (2006) Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27(11): 1289-1297.
8. Suleiman M, Hammerman H, Boulos M et al (2005) Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111(6): 754-760.
9. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini GF (2007) Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 114(2): 176-182.
10. Cheng HH, Yen PC (2010) Killip classification and glucose level in patients with acute myocardial infarction. Am J Emerg Med 28(8): 853-856.
11. Vis MM, Sjauw KD, van der Schaaf RJ, Baan J Jr, Koch KT, DeVries JH, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP (2007) In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J 154(6): 1184-1190.
12. Pres D, Gasior M, Strojek K, Gierlotka M, Hawranek M, Lekston A, Wilczek K, Tajstra M, Gumprecht J, Poloński L (2010) Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. Kardiol Pol 68(7): 743-751.
13. Nishio K, Shigemitsu M, Kusuyama T et al (2006) Insulin resistance in nondiabetic patients with acute myocardial infarction. Cardiovasc Revasc Med 7(2): 54-60.
14. Wallander M, Bartnik M, Efendic S (2005) Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 48(11): 2229-2235.
15. Lazzeri C, Sori A, Chiostri M, Picariello C, Gensini GF, Valente S (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26(10): 856-862.
16. Caccamo G, Bonura F, Bonura F, Vitale G, Novo G, Evola S, Evola G, Grisanti MR, Novo S (2010) Insulin resistance and acute coronary syndrome. Atherosclerosis 211(2): 672-675.
17. Kosiborod M, Inzucchi SE, Spertus JA et al (2009) Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation 119(14): 1899-1907.
18. Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L, International Working Group on Acute Heart Failure Syndromes (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112(25): 3958-3968.
19. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29(19): 2388-2442.
20. Pang PS, Komajda M, Gheorghiade M (2010) The current and future management of acute heart failure syndromes. Eur Heart J 31(7): 784-793.
21. Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, Gibler WB, McCord JK, Parshall MB, Francis GS, Gheorghiade M; on behalf of the American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (2010) Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims. A scientific statement from the American Heart Association. Circulation 122: 1975-1996.
22. Sharon AH, William TA, Marshall HC et al (2009) Focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol 53: e1-e90.
23. Thygesen K, Alpert JS, Harvey D (2007) Universal definition of myocardial infarction. Eur Heart J 28: 2525-2538.
24. Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A et al (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1): 84-89.
25. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction), American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116(7): e148-304.
26. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF (2010) Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers A single center experience. Int J Cardiol 138(2): 206-209.
27. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Intern Emerg Med (epub ahead of print).
28. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Intern Emerg Med (epub ahead of print).
29. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Uric acid in the early risk stratification of ST elevation myocardial infarction. Intern Emerg Med (in press).
30. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9): 604-612.
31. Balkau B, Charles M for the European Group for the Study of Insulin Resistance (EGIR) (1999) Comment on the provisional report from the WHO Consultation. Diabet Med 16: 442-443.
32. Muniyappa R, Lee S, Chen H, Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 294(1): E15-E26.
33. Allen LA, Hernandez AF, O'Connor CM, Felker GM (2009) End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol 53(24): 2248-2258.
34. Shook MS, Zafarullah H, Nelson MD, Bhattacharya SK, Davis RC, Newman KP, Weber KT (2009) Normoglycemia in nondiabetic African Americans hospitalized with heart failure. Am J Med Sci 338(4): 255-258.
35. Novack V, Pencina M, Zahger D, Fuchs L, Nevzorov R, Jotkowitz A, Porath A (2010) Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One 5(8): e12184.
36. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML (2009) Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37(12): 3001-3009.
37. Testani JM, McCauley BD, Kkimmel SE, Shannon RP (2010) Characteristics of patients with improvement of worsening in renal function during treatment of acute decompensated heart failure. Am J Cardiol 106: 1763-1769.
38. Noria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51: 1268-1274.